Notably, several studies have demonstrated IL‐1R2 abnormal expression in various cancers, such as lung cancer (Fennell et al., 2014), prostate cancer (Jones et al., 2013), and adrenocortical cancer (Szabo et al., 2014). The gene discussed is IL1R2; the disease is lung carcinoma.